Related references
Note: Only part of the references are listed.Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis
Hugo Perazzo et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)
High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study
Maria Elisa Mancuso et al.
LIVER INTERNATIONAL (2020)
High rate of SVR with DAA in haemophiliacs with HCV infection: Three decades of follow-up of a Portuguese single-centre cohort
Tiago P. Guedes et al.
LIVER INTERNATIONAL (2020)
Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations
George Lau et al.
HEPATOLOGY INTERNATIONAL (2020)
COVID-19 and viral hepatitis elimination programs: Are we stepping backward?
Hamidreza Karimi-Sari et al.
LIVER INTERNATIONAL (2020)
Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection
Hong Xiao et al.
MEDICINE (2019)
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/ sofosbuvir hepatitis C treatment in a single centre in Germany
Peter Buggisch et al.
PLOS ONE (2019)
Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience
Lennert Fransen et al.
HAEMOPHILIA (2019)
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
Roberta D'Ambrosio et al.
JOURNAL OF HEPATOLOGY (2019)
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Raymond T. Chung et al.
CLINICAL INFECTIOUS DISEASES (2018)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C
Maryam Keshvari et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2017)
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection
Paul Kwo et al.
GASTROENTEROLOGY (2017)
Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naive or Treatment-Experienced
Hyun Woong Lee et al.
GUT AND LIVER (2017)
Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
C. E. Walsh et al.
HAEMOPHILIA (2017)
Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection
Heidar Sharafi et al.
HEPATITIS MONTHLY (2017)
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
Seyed Moayed Alavian et al.
HEPATITIS MONTHLY (2017)
The Impact of Ledipasvir/Sofosbuvir on HIV-Positive and HIV-Negative Japanese Hemophilia Patients With 1, 4, and Mixed-Genotype HCV
Azusa Nagao et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study
Qing-Lei Zeng et al.
JOURNAL OF HEPATOLOGY (2017)
EASL Recommendations on Treatment of Hepatitis C 2016
JOURNAL OF HEPATOLOGY (2017)
Micro-elimination - A path to global elimination of hepatitis C
Jeffrey V. Lazarus et al.
JOURNAL OF HEPATOLOGY (2017)
Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders
Haruka Uemura et al.
PLOS ONE (2017)
Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism
Ramesh Saeedi et al.
ANNALS OF HEPATOLOGY (2017)
Once daily ledipasvir/sofosbuvir fixed-dose combination with ribavirin in patients with inherited bleeding disorders and hepatitis C genotype 1 infection
C. A. M. Stedman et al.
HAEMOPHILIA (2016)
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
Seyed Moayed Alavian et al.
HEPATITIS MONTHLY (2016)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis
Seyed Moayed Alavian et al.
Hepatitis Monthly (2012)
Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis
Massimo Franchini et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Share Paper
